Selected article for: "cost burden and health care"

Author: Zhang, T; Lee, T K; Lui, H; Dutz, J; Dawes, M; Lee, A; Kalia, S
Title: Health insurance claim- and prescription record-based algorithms as a population-based method for eczema ascertainment.
  • Cord-id: ax2f43y6
  • Document date: 2020_2_26
  • ID: ax2f43y6
    Snippet: Eczema (atopic eczema) is a common, chronic and recurrent inflammatory skin disease affecting 10-15% of the population. A limited Canadian study based on a small survey sample reported that the annual cost of eczema is $CAD 1.4 billion dollars, with costs expected to rise further with the introduction of biologic therapies. Its growing global prevalence, the reduced quality of life, and the increased cost of care makes eczema a significant public health burden.
    Document: Eczema (atopic eczema) is a common, chronic and recurrent inflammatory skin disease affecting 10-15% of the population. A limited Canadian study based on a small survey sample reported that the annual cost of eczema is $CAD 1.4 billion dollars, with costs expected to rise further with the introduction of biologic therapies. Its growing global prevalence, the reduced quality of life, and the increased cost of care makes eczema a significant public health burden.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date